Death Receptor-induced Apoptosis Reveals a Novel Interplay between the Chromosomal Passenger Complex and CENP-C during Interphase
Mol. Biol. Cell Faragher et al.
18: 1337
Supplemental Material
This article contains the following supporting material:
Supplemental Figure 1
-
TRAIL induces a time-dependent processing of caspase-8. MCF-7 cells were exposed to TRAIL (1 μg ml-1) and the processing of caspase-8 assessed by western blotting using an antibody that detects the unprocessed zymogen and the processed catalytically active large subunit. The p18 large subunit was detected after 15 min of treatment.
Supplemental Figure 2
-
Cleaved caspase-8 can be translocated into the nucleus. MCF-7 cells were permeablized with digitonin (40 μg ml-1) for 5 min on ice and then incubated with recombinant active caspase-8 (600 ng ml-1) for a further 30 min at 37°C. Where indicated, nuclei were pre-treated with WGA (50 μg ml-1) for 15 min at room temperature prior to incubation with caspase-8. The cells were then fixed and labelled with either the cleaved caspase-8 antibody (green), which labels only the processed p10 subunit of caspase-8 or with a second caspase-8 antibody that detects the intact zymogen, the p43/41 and p18 processed forms. The nuclei were also stained with Hoechst 33258 (blue). Bar, 15 μm.These results show that cleaved caspase-8 can enter the nucleus and this can be prevented by pre-treatment with WGA.
Supplemental Figure 3
-
Cleaved caspase-8 does not co-localize with PIKA or PML bodies. (A) MCF-7 cells were treated with TRAIL (1 μg ml-1) for 1 h and labelled with antibodies against PIKA (red), cleaved caspase-8 (green) and Hoechst (blue). Arrow indicates the PIKA body and shows that there was no co-localization of the signals. (B) A549 cells were treated with TRAIL (1 μg ml-1) for 1 h and labelled with antibodies against PML protein to highlight the PML bodies (red), cleaved caspase-8 (green) and Hoechst 33258 (blue). Bar, 8 μm.
Supplemental Figure 4
-
Staurosporine induces a time dependent loss of CENP-C labelling. MCF-7 cells were exposed to staurosporine (STS 1 μM) for 4-6 h either alone or in the presence of z-VAD.fmk (50 μM). Cells were then labelled with an antibody against CENP-C (554) (red) and stained with Hoechst 33258 (blue). Staurosporine induced a time-dependent loss of CENP-C labelling that was prevented by z-VAD.fmk, indicating that caspase activation rather than protein kinase inhibition was responsible for the loss of CENP-C labelling.
Supplemental Figure 5
-
Knockdown of caspase-7 protects against the loss of CENP-C. (A) MCF-7 cells were transfected for 24 h with either scrambled, XIAP or three different caspase-7 siRNA oligonucleotides (100 nM) and then re-transfected 24 h later. All three caspase-7 oligonucleotides caused depletion of caspase-7 but did not affect levels of caspase-8 and –6. (B) Bcl-xL over-expressing MCF-7 cells, used to minimize involvement of the intrinsic pathway, were exposed to TRAIL (1 μg ml-1) for 3 h following transfection of the cells as described in (A) but using only oligonucleotide 3 caspase-7 siRNA (100 nM). Following labelling of the cells with CENP-C antibodies, confocal microscopy was used to score the number of cells without label. There was a highly significant decrease (p<0.01) in the median % of cells without CENP-C following exposure to TRAIL for 3 h (n=3).